Yu Fan

13F Portfolio Filings

  • Most recent 13F
    Q4 2024
  • Location
    central, hong kong, K3
  • CIK
    0001668029
  • All SEC filings
Q4 2024
Quater
Holdings
VALUE
Top Holdings
Form Type
Date Filed
Filing Id

7

$53.24M
CERIBELL INC, CRGX, ALMS, CGON
13F-HR
Feb 14, 2025
000095012325002400

6

$32.48M
CRGX, ALMS, CGON, CSTL
13F-HR
Nov 14, 2024
000095012324011471

6

$76.53M
CGON, CRGX, ALMS, CSTL
13F-HR
Aug 14, 2024
000095012324008418

5

$72.54M
PRENETICS GLOBAL LTD, AGLE, SONX, SGMT
13F-HR
May 15, 2024
000095012324005233

4

$19.95M
CRGX, CSTL, SGMT, PYXS
13F-HR
Feb 14, 2024
000095012324002149

5

$1.41M
SGMT, SONX, AGLE, PYXS
13F-HR
Nov 14, 2023
000095012323010790

5

$1.27M
SONX, CSTL, APGN, AGLE
13F-HR
Aug 14, 2023
000095012323008115

5

$1.82M
SONX, CSTL, APGN, AGLE
13F-HR
May 15, 2023
000095012323004998

6

$7.47M
ABG ACQUISITION CORP I, SONX, CSTL, APGN
13F-HR
Feb 14, 2023
000095012323002328

6

$7.34M
ABG ACQUISITION CORP I, APGN, SONX, CSTL
13F-HR
Nov 14, 2022
000095012322011718

5

$6.46M
ABG ACQUISITION CORP I, SONX, CSTL, PRENETICS GLOBAL LTD
13F-HR
Aug 15, 2022
000095012322009122

4

$7.39M
ABG ACQUISITION CORP I, SONX, AGLE, DIFFUSION PHARMACEUTICALS IN
13F-HR
May 16, 2022
000095012322005937

4

$8.62M
ABG ACQUISITION CORP I, SONX, AGLE, DIFFUSION PHARMACEUTICALS IN
13F-HR
Feb 14, 2022
000095012322002424

3

$5.82M
ABG ACQUISITION CORP I, AGLE, DIFFUSION PHARMACEUTICALS IN
13F-HR
Nov 15, 2021
000095012321015119

4

$8.85M
ABG ACQUISITION CORP I, AVIR, AGLE, DIFFUSION PHARMACEUTICALS IN
RESTATEMENT
Sep 17, 2021
000095012321012428

5

$38.31M
AVIR, LUNG, ABG ACQUISITION CORP I, AGLE
RESTATEMENT
Sep 17, 2021
000095012321012427

1

$20.91M
LUNG
NEW HOLDINGS
May 17, 2021
000095012321006743

3

$13.49M
AVIR, AGLE, DIFFUSION PHARMACEUTICALS IN
13F-HR
Feb 16, 2021
000095012321002356
Yu Fan 13F Filings